Quest PharmaTech Inc. — Regulatory Filings 2020

Jun 27, 2020

Note: [01 Mar 2017] – The following is a consolidation of 13-501F1. It incorporates amendments to this documentthat came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative.

FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS -PARTICIPATION FEE

MANAGEMENT CERTIFICATION

I, Pierre Vermette	an officer of the reporting issuer noted below have examined this
Form 13-501F1 (the Form) being submitted hereunder to the Alberta Securities Commission and
certify that to my knowledge, having exercised reasonable diligence, the information provided inthe Form is complete and accurate.
		June 26, 2020
Name: Pierre Vermette	Date:
Title:Chief Financial Officer
Reporting Issuer Name:	Quest PharmaTech Inc.
End date of previous financial year:	January 31, 2020
Type of Reporting Issuer:	$[\times]$ Class 1 reportingissuer	issuer	] Class 3B reporting
Highest Trading Marketplace:	TSX Venture Exchange
Market value of listed or quoted equity securities:
Equity Symbol		QPT.v
1st Specified Trading Period (dd/mm/yy)		01/02/19to	30/04/19
Closing price of the security in the class or series on the
last trading day of the specified trading period in whichsuch security was listed or quoted on the highest tradingmarketplace
		$(i)	0.1400

Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day of			167,389,247
the specified trading period		(ii)
	$(i)$ x $(ii)$			23,434,494.58
Market value of class or series		(A)
2nd Specified Trading Period (dd/mm/yy)		01/05/19	to	31/07/19
Closing price of the security in the class or series on thelast trading day of the specified trading period in which
such security was listed or quoted on the highest trading				0.1200
marketplace		(iii)
Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day of				167,389,247
the specified trading period		(iv)
	$(iii)$ x $(iv)$	$		20,086,709.64
Market value of class or series		(B)
3rd Specified Trading Period (dd/mm/yy)		01/08/19	to	31/10/19
Closing price of the security in the class or series on thelast trading day of the specified trading period in which
such security was listed or quoted on the highest trading		$		0.1200
marketplace		(v)
Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day of				167,389,247
the specified trading period		(v i )
	$(v)$ x $(vi)$	$		20,086,709.64
Market value of class or series		(C)

4th Specified Trading Period (dd/mm/yy)01/11/19Closing price of the security in the class or series on thelast trading day of the specified trading period in whichsuch security was listed or quoted on the highest tradingmarketplace		31/01/20tο
		0.1200
Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day ofthe specified trading period	(viii)	167,749,247
$(vii)$ x $(viii)$Market value of class or series	(D)	20,129,909.64
5th Specified Trading Period (dd/mm/yy)		τo
Closing price of the security in the class or series on thelast trading day of the specified trading period in whichsuch security was listed or quoted on the highest tradingmarketplace	(ix)
Number of securities in the class or series of suchsecurity outstanding at the end of the last trading day ofthe specified trading period	(x)
$(ix)$ x $(x)$Market value of class or series	$(E)
Average Market Value of Class or Series (Calculatethe simple average of the market value of the class orseries of security for each applicable specified tradingperiod (i.e. A through E above))		20,934,456

(Repeat the above calculation for each other class or series of equity securities of the reporting issuer (and a subsidiary, if applicable) that was listed or quoted on a marketplace at the end of the previous financial year)

Fair value of outstanding debt securities:

(Provide details of how value was determined)

Capitalization for the previous financial year

Participation Fee

Late Fee, if applicable

Total Fee Payable (Participation Fee plus Late Fee)